Specialty Pharmacy

Experimental combination shows similar rates of HIV virologic suppression to Truvada.

Experimental drug may allow patients to take one dose per month.

Black women diagnosed with breast cancer at or below age 50 have a much higher instance of BRCA mutation.

HIV viral suppression at the time of birth much worse than expected.

Genetic profiling after initial chemotherapy may help oncologists predict early prognosis.

Pharmacists are conspicuously absent from treatment teams for cancer survivors.

Tumors linked to high blood sugar can be successfully treated without affecting blood vessel growth.

Daratumumab causes the targeted killing of CD38-carrying tumor cells.

As pediatric survival rates improve, long-term problems arise from other factors.

Vaccine primes immune cells to attack patient-specific tumor tissue.

Study finds a pattern of disconnectivity among executive areas of the brain.

Class of receptors may be precisely targeted by drug compounds.

Study finds substantial minority living with undiagnosed HIV infection.

Autobiographical memory and episodic future thinking reduced in MS patients.

The latest news in oncology treatment research.

Both conditions are separate diseases with different causes, diagnostic procedures, and treatments.

Study finds public opinion surrounding medical marijuana may influence treatment decisions.

Some complementary or alternative medications can have an adverse reaction mixed with cancer drugs.

Advocates seek to eradicate the disease by 2030.

Biologic therapy targets genetic defects found in various cancers.

Top stories of the week on Specialty Pharmacy Times.

Baked potato extract found to suppress the spread of colon cancer stem cells.

Study suggests testing sites in high schools may increase the likelihood of getting an HIV test.

Study shows nitroglycerin may improve the delivery of anticancer drugs.

Health care providers urged to counsel lung transplant recipients on the risks connected with skin cancer, light protection, and routine screening.

Minor benefit found adult patients with grade II, or moderate, COPD when adding aclidinium bromide and formoterol.

Obesity leads to biomechanical changes that create the right conditions for tumor growth.

Varubi prevents nausea and vomiting associated with vomit-inducing cancer chemotherapy.